Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 9,679 | 11,740 | 20,319 | 1,948 | 938 |
| Cost of Goods | 16,137 | 21,410 | 34,788 | 5,048 | 1,223 |
| Gross Profit | -6,458 | -9,670 | -14,469 | -3,099 | -286 |
| Operating Expenses | 14,274 | 17,326 | 36,543 | 34,245 | 8,811 |
| Operating Income | -20,732 | -26,996 | -51,012 | -37,344 | -9,097 |
| Interest Expense | 700 | 4,973 | N/A | 219 | 0 |
| Other Income | -17,735 | -11,374 | -61,994 | 6,556 | 255 |
| Pre-tax Income | -39,167 | -43,343 | -113,005 | -31,007 | -8,842 |
| Income Tax | 0 | 196 | -1,099 | -24 | 0 |
| Net Income Continuous | -39,167 | -43,539 | -111,907 | -30,983 | -8,842 |
| Minority Interests | 0 | 587 | 766 | 407 | 110 |
| Net Income | $-39,167 | $-42,952 | $-111,141 | $-30,577 | $-8,732 |
| EPS Basic Total Ops | -0.19 | -0.22 | -0.75 | -0.22 | -0.10 |
| EPS Basic Continuous Ops | -0.19 | -0.22 | -0.75 | -0.22 | -0.10 |
| EPS Diluted Total Ops | -0.19 | -0.22 | -0.75 | -0.22 | -0.10 |
| EPS Diluted Continuous Ops | -0.19 | -0.22 | -0.75 | -0.22 | -0.10 |
| EBITDA(a) | $-35,613 | $-33,550 | $-44,582 | $-27,341 | $-8,559 |